文献速递烧伤创面修复

重组人胶原蛋白水凝胶治疗部分厚度烧伤的前瞻性自身对照临床研究

A recombinant human collagen hydrogel for the treatment of partial-thickness burns: A prospective, self-controlled clinical study.
PubMed 文献 · Burns · 2021-01-02

结果显示两组创面愈合时间无统计学显著差异,异种皮中位愈合天数为11.00 ± 0.56,RHCH为11.00 ± 1.72。研究表明RHCH在观察期内对部分厚度烧伤创面的治疗效果与基因转移异种皮无显著差异,具有临床使用潜力。

要点

  • RHCH与基因转移异种皮治疗部分厚度烧伤的愈合时间无显著差异。
  • 异种皮中位愈合天数为11.00 ± 0.56,RHCH为11.00 ± 1.72。
  • RHCH在观察期内表现出治疗部分厚度烧伤的临床潜力。

核心结论

  • 在观察期内,RHCH对部分厚度烧伤创面的治疗效果与基因转移异种皮无显著差异,具有临床使用潜力。

主要发现

  • 两组创面愈合时间无统计学显著差异,异种皮中位愈合天数为11.00 ± 0.56,RHCH为11.00 ± 1.72。
  • 在入组第0、5、10、15、20天记录创面情况,并在第0、10、20天或创面愈合日进行细菌药敏试验、血尿检查及心电图检查。

关键数值与推荐

  • 异种皮中位愈合天数为11.00 ± 0.56,RHCH为11.00 ± 1.72(原文报告为均值±标准差形式)。

临床怎么用

  • RHCH可作为部分厚度烧伤创面的一种潜在覆盖材料,在缺乏异种皮供应时考虑使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Allogeneic and xenogeneic skin are recognized as the best coverings for skin burn wounds, but currently face a supply shortage. To solve this problem, our research group developed a standardized manufactured hydrogel dressing based on a new type of highly bioactive recombinant human collagen. STUDY DESIGN: Prospective self-controlled trial. OBJECTIVE: To evaluate the efficacy and safety of recombinant human collagen hydrogel in the treatment of partial burn wounds to the skin compared to those of xenogeneic skin. METHODS: This study included twenty-one patients admitted to Shanghai Changhai Hospital within 48 h after receiving partial-thickness skin burns. The wounds were symmetrically separated along the axis and treated with recombinant human collagen hydrogel (RHCH) or a human-CTLA4-Ig gene-transferred pig skin xenotransplant. The condition of the wound surfaces was recorded on days 0 (of enrollment), 5, 10, 15, and 20, and bacterial drug sensitivity testing, hematuria examination, and electrocardiographic tests were conducted on days 0, 10, 20, or on the day of wound healing. RESULTS: There were no statistically significant differences in wound healing time between the two groups. The median number of days to healing was 11.00 ± 0.56 for xenogeneic skin vs. 11.00 ± 1.72 for RHCH. CONCLUSION: During the observation period, the therapeutic effect of the RHCH developed by our group on partial-thickness burn wounds was not significantly different from that of gene-transferred xenogeneic skin. Thus, our designed RHCH shows potential for clinical use to treat burn wounds on the skin.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Ben C, Liu X, Shen T, et al. A recombinant human collagen hydrogel for the treatment of partial-thickness burns: A prospective, self-controlled clinical study. Burns. 2021. PMID: 33402311. doi:10.1016/j.burns.2020.01.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。